No Data
Huakang Biomed (08622): Xu Ming has been appointed as a non-executive director.
huakang biomed (08622) announced that Xu Ming has been appointed as a non-executive director of the company, effective from October 2024...
HUAKANG BIOMED: 2024 INTERIM REPORT
Huakang Biomed (08622) announced its interim results, with a net loss of approximately 1.779 million yuan attributable to owners, a 22.27% year-on-year increase in the loss.
Huakang Biomed (08622) announced its 2024 interim performance, with revenue increasing by about 4% YoY to 11.9 million yuan...
HUAKANG BIOMED: INTERIM RESULTS ANNOUNCEMENTFOR THE SIX MONTHS ENDED 30 JUNE 2024
Hang Seng Index: Benefiting from policy support, biotechnology stocks have seen three consecutive months of inflows.
The Hang Seng Index company stated that there are signs of improvement in the recent situation of biotechnology stocks, as well as benefitting from policy support and three consecutive months of inflow of funds.
HK stocks surge | Huakang Biomedical (08622) rose more than 40% in mid-day trading, planning to carry out online store and enzyme-based product trade business.
Huakang Biomedical (08622) rose more than 40% in intraday trading. As of press time, it has risen 31.63%, with a share price of HKD 0.129 and a turnover of HKD 0.401 million.
Huakang Biomedical Holdings Vice Chairman Yim Yang Chang Sells 31% Of Holding
No Data
